Current Opinion in Hematology

Papers
(The TQCC of Current Opinion in Hematology is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Novel blood derived hemostatic agents for bleeding therapy and prophylaxis68
Editorial: the new age of clinical research in clonal hematopoiesis and myeloid malignancies47
Posttransplant cyclophosphamide: a universal graft versus host disease prophylaxis46
Hormetic endoplasmic reticulum stress in hematopoietic stem cells44
IRAK1 and IRAK4 as emerging therapeutic targets in hematologic malignancies24
Novel immune directed therapies in myelodysplastic syndromes and acute myeloid leukemia24
Heme- and iron-activated macrophages in sickle cell disease: an updated perspective23
Deficits in our understanding of natural killer cell development in mouse and human23
Emerging therapeutic and preventive approaches to transplant-associated thrombotic microangiopathy19
Mechanisms of immunothrombosis in COVID-1918
Interferon regulatory factor-8-dependent innate immune alarm senses GATA2 deficiency to alter hematopoietic differentiation and function18
Disparities in acute myeloid leukemia treatments and outcomes17
Regulation and importance of factor VIII levels in hemophilia A carriers17
Adenosine signaling in promoting the balance between erythropoiesis and myelopoiesis16
Developmental regulation of primitive erythropoiesis16
Congenital neutropenia: disease models guiding new treatment strategies15
The new world: hematopoietic stem cell transplant during a pandemic15
The impact of obesity-induced inflammation on clonal hematopoiesis15
Unraveling lipid metabolism for acute myeloid leukemia therapy14
Platelet lifespan and mechanisms for clearance14
Clonal hematopoiesis and myeloid malignancies: clonal dynamics and clinical implications13
Editorial introductions12
Abnormal monocyte differentiation and function in chronic myelomonocytic leukemia12
Editorial introduction11
Editorial introductions11
Significance and management of isolated distal deep vein thrombosis11
Targeting the cluster of differentiation 47/signal-regulatory protein alpha axis in myeloid malignancies10
Tissue factor pathway inhibitor – cofactor-dependent regulation of the initiation of coagulation10
Haematopoietic stem cell quiescence exposed using mitochondrial membrane potential10
Understanding and targeting erythroid progenitor cells for effective cancer therapy9
Signaling mechanisms and cis-regulatory control of Samd14 in erythroid regeneration9
Thrombosis in myeloproliferative neoplasms: update in pathophysiology9
Red cells: not only hemoglobin – plasma membranes are also of paramount importance9
Platelets in vascular inflammation: fire-fighters or pyromaniacs?9
Editorial introductions9
Red blood cell changes due to cancer and cancer treatments: a narrative review8
Current Opinion in Hematology8
Venous thromboembolism: diagnostic advances and unaddressed challenges in management8
A role of platelet C-type lectin-like receptor-2 and its ligand podoplanin in vascular biology7
The immunology of PF4 polyanion interactions7
Modelling arterial thrombus formation in vitro7
Modeling genetic platelet disorders with human pluripotent stem cells: mega-progress but wanting more on our plate(let)7
Translation defects in ribosomopathies7
Editorial introductions7
Update on preclinical and clinical efforts on ex-vivo expansion of hematopoietic stem and progenitor cells7
Challenges and opportunities in shared care for international patients treated with cellular therapy for nonmalignant disease6
Editorial introduction6
Platelet mitochondria: the mighty few6
Measurement of tissue factor-positive extracellular vesicles in plasma: strengths and weaknesses of current methods6
Chediak-Higashi syndrome6
PROTACs in platelets: emerging antithrombotic strategies and future perspectives6
The fulfilled promise and unmet potential of umbilical cord blood6
Models to study myelodysplastic syndrome and acute myeloid leukaemia6
0.12188696861267